Trial Profile
To evaluate the efficacy and safety of Ingenol mebutate as a treatment of Hydroxyurea induced Squamous Dysplasia lesions:a single center study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis; Epithelial dysplasia
- Focus Adverse reactions; Therapeutic Use
- 18 May 2017 New trial record